Results of comparison between Model5 and Model9. by Taiga Mori (21410076)

Results of comparison between Model5 and Model10. by Taiga Mori (21410076)

Negative ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

Serotype-specific penicillin non-susceptibility during different PCV periods in Iceland, Romania, Spain and Belgium [68, 69, 76, 78, 84, 85]. by Heloisa Ricci Conesa (18291210)

Subjects:

Procedures of sampling and measurements. by Xuegang Mao (599968)

Subjects:

Introduction status of PCVs in European countries over time. by Heloisa Ricci Conesa (18291210)

Subjects:

Data extraction grid. by Heloisa Ricci Conesa (18291210)

Subjects:

Incidence rates of AOM cases. by Heloisa Ricci Conesa (18291210)

Subjects:

Inclusion criteria. by Heloisa Ricci Conesa (18291210)

Subjects:

PRISMA flow diagram for the literature search. by Heloisa Ricci Conesa (18291210)

Subjects:

Estimates for direct medical and total costs per AOM episode (2020 EUR), by country [35, 96–100]. by Heloisa Ricci Conesa (18291210)

Subjects:

Vertical distributions in the three field settings. by Xuegang Mao (599968)

Subjects:

Fig 5 - by Kellie J. Walters (10451329)

Subjects:

<i>prx-5/6</i> mutations likely cause a decrease in mmBCFA degradation. by Rencheng Wang (463927)

“…<i>elo-5</i>(<i>lf</i>)<i>; Ex</i>[<i>elo-6</i>] is a transgenic strain that significantly overexpressed the <i>elo-6</i> gene and was not sufficient to suppress the L1 arrest phenotype of <i>elo-5</i>(<i>lf</i>). …”

HAstV-1 infection leads to a decrease in epithelial markers while increasing mesenchymal markers. by Virginia Hargest (12447014)

Heterocene Catalysts and Reaction Temperature Gradient in Dec-1-ene Oligomerization for the Production of Low Viscosity PAO Base Stocks by Ilya E. Nifant’ev (1561813)

Subjects:

CYP3A94 activity is significantly increased in V79-CYP3A94/DD-POR cells, but decreases after incubation with Shield-1. by Ramona Dettwiler (664360)

Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy. by Molly B. El Alam (10231830)

Both (A) parametric and (B) non-parametric analyses suggest that the bacterial community composition shifts between 5.18 and 7.12 mg O₂ L^-1. by Rachel L. Spietz (782905)